Old Web
English
Sign In
Acemap
>
authorDetail
>
Phillip M. Bartholomew
Phillip M. Bartholomew
Pfizer
Endocrinology
Internal medicine
Carcinogen
Biology
STAT protein
5
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development
2017
Regulatory Toxicology and Pharmacology
Zaher A. Radi
W. Mark Vogel
Phillip M. Bartholomew
Petra Koza-Taylor
Alexandros Papanikolaou
Todd Wisialowski
Prashant R. Nambiar
Douglas J. Ball
Show All
Source
Cite
Save
Citations (3)
Injection-site Malignant Fibrous Histiocytomas in a Pegvisomant Carcinogenicity Study in SD Rats:
2014
Toxicologic Pathology
Phillip M. Bartholomew
John M. Kreeger
Daniel Morton
Show All
Source
Cite
Save
Citations (1)
Chapter 27 – Carcinogenicity Assessment
2013
Daniel Morton
Carl L. Alden
Phillip M. Bartholomew
John M. Kreeger
Laura Dill-Morton
Show All
Source
Cite
Save
Citations (1)
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
2013
Toxicology and Applied Pharmacology
Zaher A. Radi
Phillip M. Bartholomew
Michael R. Elwell
W. Mark Vogel
Show All
Source
Cite
Save
Citations (5)
Chapter 27 – Carcinogenicity Assessment
2013
Daniel Morton
Carl L. Alden
Phillip M. Bartholomew
John M. Kreeger
Laura Dill-Morton
Show All
Source
Cite
Save
Citations (1)
1